Business
Notice of Annual General Meeting in Medistim ASA
Notice of Annual General Meeting in Medistim ASA
About this update from Medistim Asa
(Oslo, 10th of April 2025) Medistim ASA (OSE: MEDI), a niche market leaderwithin ultrasound technology with headquarters in Norway, that develops andcommercializes medical equipment for use within cardiac, vascular andtransplantsurgery, announces the Annual General Meeting for the company.The Annual General Meeting will take place on the 8th of May 2025 at 10.00and is held at Medistim's offices at Økernveien 94 in Oslo. Attached are theagenda for the meeting, the voting form and the annual report for 2024. It ispossible to give proxy with and without voting instructions. By using a proxywith voting instructions, the shareholders will vote on the specific issueswithout personal attendance. For further information on the use of proxy, seegeneral information at the bottom of the notice and enclosed proxy forms.Attached is also the annual report for 2024 for Medistim ASA in PDF format andin ESEF format. The report is also available on the company web site:www.medistim.com.About Medistim:Medistim was established in 1984 and has a track record of profitable growthover the past >15 years. The company is a pioneer within its segment, andcontinues to invest in new product development. Medistim has wholly ownedsubsidiaries with sales organizations in the USA, Canada, China, Germany, UK,Spain, Denmark, Sweden and Norway, in addition to the about 60 distributors inEurope, Asia, Middle East, Africa, Canada and South America. For moreinformation, visit the Medistim home page: www.Medistim.comThis information is subject to the disclosure requirements pursuant to section5-12 of the Norwegian Securities Trading Act (Verdipapirhandelloven).For more information, contact:President and CEO, Kari E. Krogstad, Medistim ASATel: + 47 918 38 110Email: [email protected], Thomas Jakobsen, Medistim ASATel: + 47 906 59 940Email: [email protected]://newsweb.oslobors.no/message/643408